Dingdang Health Technology Group Ltd.

SEHK:9886 Stock Report

Market Cap: HK$461.8m

Dingdang Health Technology Group Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Dingdang Health Technology Group.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Consumer Retailing earnings growth23.1%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

Low

Last updated17 Jan 2025

Recent future growth updates

Recent updates

Is Dingdang Health Technology Group (HKG:9886) In A Good Position To Invest In Growth?

Feb 17
Is Dingdang Health Technology Group (HKG:9886) In A Good Position To Invest In Growth?

Dingdang Health Technology Group Ltd. (HKG:9886) Stocks Pounded By 42% But Not Lagging Industry On Growth Or Pricing

Jun 13
Dingdang Health Technology Group Ltd. (HKG:9886) Stocks Pounded By 42% But Not Lagging Industry On Growth Or Pricing

We Think Dingdang Health Technology Group (HKG:9886) Can Easily Afford To Drive Business Growth

Apr 16
We Think Dingdang Health Technology Group (HKG:9886) Can Easily Afford To Drive Business Growth

We Think Dingdang Health Technology Group (HKG:9886) Can Easily Afford To Drive Business Growth

Dec 12
We Think Dingdang Health Technology Group (HKG:9886) Can Easily Afford To Drive Business Growth

We Think Dingdang Health Technology Group (HKG:9886) Can Easily Afford To Drive Business Growth

Jul 26
We Think Dingdang Health Technology Group (HKG:9886) Can Easily Afford To Drive Business Growth

Estimating The Intrinsic Value Of Dingdang Health Technology Group Ltd. (HKG:9886)

Dec 15
Estimating The Intrinsic Value Of Dingdang Health Technology Group Ltd. (HKG:9886)

Earnings and Revenue Growth Forecasts

SEHK:9886 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20256,026-10N/A1021
12/31/20244,669-376-36-11N/A
9/30/20244,773-287-99-76N/A
6/30/20244,877-198-161-140N/A
3/31/20244,867-212-91-73N/A
12/31/20234,857-226-21-5N/A
9/30/20234,722-1,297-44-28N/A
6/30/20234,587-2,368-67-50N/A
3/31/20234,465-2,491-169-146N/A
12/31/20224,329-2,833-264-238N/A
9/30/20224,177-1,951-259-233N/A
6/30/20224,025-1,069-255-228N/A
3/31/20223,886-1,232-290-266N/A
12/31/20213,679-1,578-320-295N/A
12/31/20202,229-924-215-193N/A
12/31/20191,276-277-292-266N/A
12/31/2018585-108-110N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 9886's forecast earnings growth is above the savings rate (2.4%).

Earnings vs Market: Insufficient data to determine if 9886's earnings are forecast to grow faster than the Hong Kong market

High Growth Earnings: Insufficient data to determine if 9886's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 9886's revenue is forecast to grow faster than the Hong Kong market.

High Growth Revenue: Insufficient data to determine if 9886's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 9886's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/30 21:21
End of Day Share Price 2025/04/30 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Dingdang Health Technology Group Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xipeng FengChina International Capital Corporation Limited